Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,941 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02357654RecruitingPhase 4
Hormone treatment to support the uterine lining in IVF cycles
This trial tests whether a hormone called GnRH can help support the lining of the uterus after IVF, ICSI, or frozen embryo (FET) embryo transfer. It may be offered around the time of embryo transfer to improve the chances of a successful implantation.
Hasbrouck Heights, New JerseyAges 18–40 - NCT03017118Recruiting
Turmeric study for early thumb basal joint arthritis
This trial studies whether turmeric can reduce pain from “basal joint” arthritis in the thumb, especially early stages seen on X-ray. You may be a good fit if you’re having thumb base pain and meet specific exam and X-ray requirements.
Boston, MassachusettsAges 40 years+ - NCT07665892RecruitingPhase 1
Testing a new asthma drug in adults
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
Glendale, ArizonaAges 18–55 - NCT03560583Recruiting
Metoclopramide for women with poor IVF response
This trial tests metoclopramide, a medicine used for certain stomach and nausea conditions, to see if it can improve outcomes for women who have had poor response to IVF. If you fit the “poor ovarian response” definition, you may be eligible after checking the specific exclusions.
Ashkelon, Ashkelon DistrictAges 18–54 - NCT06864520Recruiting
GABA supplement for menopause symptoms
This study tests whether a natural supplement containing GABA (a chemical that helps calm the brain) can reduce menopause symptoms like hot flashes, mood swings, and sleep problems. It may be a good option if you are looking for a non-hormonal way to manage your symptoms.
Genova, ItaliaAges Any age - NCT07114055RecruitingPhase 2/Phase 3
Ebastine for diarrhea-predominant IBS
This trial tests whether ebastine, an allergy medicine, can help relieve symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D). If you have IBS-D and are at least 18, this study may offer a new option to manage your condition.
DhakaAges 18 years+ - NCT06020716RecruitingPhase 4
Antibiotics for chronic wet cough in toddlers
This study tests whether the antibiotic Augmentin helps children aged 9 months to 3 years with long-lasting wet cough (more than 4 weeks). It aims to find better ways to treat and understand this common problem in toddlers.
ÅlesundAges 9 months–3 years - NCT05966415RecruitingPhase 2
Endocalyx for heart failure with fluid overload
This Phase 2 study tests Endocalyx to treat people with heart failure who currently show signs of fluid buildup (congestion). If you qualify, you may help researchers see whether this supplement can improve symptoms and heart-failure–related measurements.
Amsterdam, North HollandAges 18–110 - NCT03675672RecruitingPhase 4
Preventing repeat bleeding from stomach or upper gut ulcers
This trial studies medicines to help stop bleeding from coming back after you’ve had an “idiopathic” stomach/upper gut ulcer bleed. It may help by reducing ulcer re-bleeding risk in people who don’t have common causes like H. pylori or common ulcer-triggering drugs.
Hong KongAges 18 years+ - NCT06505187RecruitingPhase 2
Celecoxib for Pain After Parotid Gland Surgery
This trial is testing whether the pain reliever celecoxib (Celebrex) can help control pain after a specific type of salivary gland surgery called superficial parotidectomy. If you're having this surgery, you may be able to join and take celecoxib for pain rather than other common pain medicines.
Madison, WisconsinAges 18 years+ - NCT03672760Recruiting
Breathing training app for heart vessel stiffness and stress signals
This study tests whether an inspiratory (breathing-in) muscle training program using the CardioBreath app can improve heart blood-vessel stiffness and “stress/autonomic” signaling. It targets people with a specific hormone pattern and activity level, while avoiding several common health conditions that could affect safety or results.
Porto Alegre, Rio Grande do SulAges 45–65 - NCT04476901RecruitingPhase 2
Study of donor stem cell treatment for non-ischemic heart failure
This Phase 2 trial tests whether donor “MSC” cells can improve heart function in people with non-ischemic dilated cardiomyopathy and reduced pumping strength. You may be eligible if your condition is already treated with standard heart medicines and you can safely undergo a heart catheterization and follow-up testing.
Stanford, CaliforniaAges 18–80 - NCT06196203RecruitingPhase 2
Study of AK117 with Azacitidine for High-Risk MDS
This trial tests a new drug, AK117, combined with azacitidine for people newly diagnosed with high-risk myelodysplastic syndromes (MDS), a blood disorder. The goal is to see if the combination can help improve outcomes.
Los Angeles, CaliforniaAges 18 years+ - NCT06475105RecruitingPhase 4
Acetazolamide and Furosemide for Acute Heart Failure
This trial tests whether adding an oral water pill (acetazolamide) to standard IV furosemide helps people with acute heart failure who have fluid overload. It aims to see if the combination improves outcomes better than furosemide alone.
Semarang, Central JavaAges 18 years+ - NCT06475391Recruiting
L-arginine supplement for exercise performance
This study tests whether taking L-arginine (a natural amino acid supplement) can improve your performance during short, intense exercise like sprinting or weightlifting. If you are a healthy, active adult, you may be able to join.
Winnipeg, ManitobaAges 18–39 - NCT06164613RecruitingPhase 2
Cinnamon for Inducing Labor in First-Time Teen Pregnancies
This study tests whether cinnamon capsules can help start labor in first-time pregnant teens who are full-term. It compares cinnamon to a placebo (fake pill) to see if it is safe and effective for inducing labor.
Tegucigalpa, Francisco Morazán DepartmentAges 14–45 - NCT06215716RecruitingPhase 3
Efruxifermin for NASH/MASH with liver scarring
This study tests a new medicine, efruxifermin, for people with NASH/MASH (fatty liver disease) and moderate liver scarring. It aims to see if the drug can help improve the liver's condition.
Birmingham, AlabamaAges 18–80 - NCT06377761Recruiting
Qishen granules for heart failure with preserved pumping function
This trial tests a Chinese herbal medicine called Qishen Granules for people with heart failure who still have a normal pumping ability (ejection fraction 50% or higher). It may help reduce symptoms and improve heart function.
Guangzhou, GuangdongAges 18–85 - NCT06343870RecruitingPhase 3
Hormone implants for menopause after cervical cancer or early menopause
This trial tests hormone implants (estradiol and testosterone) to treat menopause symptoms in women who have had their ovaries and uterus removed due to cervical cancer, or who have early menopause. The implants are placed under the skin and may help with hot flashes, mood, and sexual health.
São Paulo, São PauloAges 18–60 - NCT05711394RecruitingPhase 3
Atogepant for preventing episodic migraine in children
This study tests whether an oral medicine called atogepant can reduce migraine activity in children ages 6–17 and checks its side effects. It’s meant for kids with episodic migraine (not the more constant types) who may benefit from preventive treatment.
Huntsville, AlabamaAges 6–17 - NCT06422273Enrolling by invitationPhase 3
TXA vs Saline to Prevent Bleeding After Lung Transplant Biopsy
This trial tests whether a medication called tranexamic acid (TXA) can help prevent bleeding after a lung transplant biopsy. It compares TXA to a saltwater solution (saline) to see if it reduces the need for procedures to stop bleeding.
Grand Rapids, MichiganAges 18 years+ - NCT06440525RecruitingPhase 2
Testing RSLV-132 for Sjögren's disease in women
This study tests an investigational drug called RSLV-132 in women with Sjögren's disease to see if it can reduce symptoms like fatigue and dryness. You may join if you've been diagnosed in the last 30 years and have persistent symptoms.
Chula Vista, CaliforniaAges 18–75 - NCT06341335RecruitingPhase 3
AK104 and AK109 plus paclitaxel for advanced stomach cancer
This trial tests a combination of two experimental immunotherapies (AK104 and AK109) with a standard chemo drug (paclitaxel) for people with advanced stomach or gastroesophageal junction cancer that has grown after initial treatment. The goal is to see if this new combination can help shrink tumors or slow the cancer better than chemo alone.
BeijingAges 18–75 - NCT07699809Recruiting
Thirst relief kit for thirst after colonoscopy prep
This trial tests whether a 'thirst relief kit' can help reduce thirst after the bowel preparation for a colonoscopy. If you are having a colonoscopy with hospital-based bowel preparation, you may be eligible to receive the kit or a placebo (a kit without active ingredients) to see if it helps with thirst.
São Paulo, São PauloAges 18 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,941 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.